News & Insight

October 18, 2019 CrownBio launched patient-derived tumo... San Diego, October 17, 2019 – Crown Bioscience today announced the launch of a new tumor organoid drug development pl... read more
October 01, 2019 Hubrecht Organoid Technology and MIMET... Leiden, Utrecht September 2019 MIMETAS and Hubrecht Organoid Technology (HUB) announce that they entered into a strategi... read more
July 17, 2019 Epistem license Hubrecht Organoid Tech... Epistem license Hubrecht Organoid Technology to expand preclinical toxicology service portfolio Manchester, 16th July, 2... read more
July 09, 2019 ‘Het gaat alleen sneller als er geld... Hubrecht Organoid Technology, kortweg HUB, is als start-up ontstaan op de Uithof, de universiteitscampus in Utrecht. Het... read more
July 09, 2019 Medicijnen betaalbaar houden De kosten van medicijnen zijn de afgelopen 30 jaar flink gestegen. En zullen de komende jaren verder stijgen. CZ gaat ve... read more
May 17, 2019 HUB and AstraZeneca in joint presentat... Farzin Pourfarzad and AstraZeneca will present together the applications of pre-clinical animal models for toxicology st... read more
April 10, 2019 Organoid course at MDIBL from May 26 t... After our successful Organoid course last year, we would like to announce the launch of our next Organoid course on “A... read more
April 10, 2019 HUB and Yamaha Motor Announce their Co... February 1, 2019 – Hubrecht Organoid Technology (HUB) and Yamaha Motor Co., Ltd. (Tokyo:7272) announced today their co... read more
April 09, 2019 Hubrecht Organoid Technology and Crown... March 27, 2019 – Hubrecht Organoid Technology (HUB) and JSR Corporation, the parent company, of Crown Bioscien... read more